Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jardi

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Medicina Clinica|May 11, 1985
[Infection by delta agent in drug addicts]M Buti, R Esteban, J M Rodrigo, et al.
Journal of Hepatology|February 1, 1987
Anti-HD IgM as a marker of chronic delta infectionM Buti, R Esteban, J I Esteban, et al.
Journal of Medical Virology|November 1, 1988
Epidemiology of delta infection in SpainM Buti, R Esteban, R Jardi, et al.
Journal of Hepatology|May 1, 1994
Etiology of acute sporadic hepatitis in Spain: the role of hepatitis C and E virusesM Buti, R Jardi, F Rodriguez-Frias, et al.
Journal of Hepatology|April 29, 1998
Transient emergence of hepatitis B variants in a patient with chronic hepatitis B resistant to lamivudineM Buti, R Jardi, M Cotrina, et al.
The Journal of Infectious Diseases|March 23, 2001
Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis BM Buti, F Sánchez, M Cotrina, et al.
Progress in Clinical and Biological Research|January 1, 1993
Serological diagnosis of chronic delta infection: correlation between serological markers and hepatitis delta virus RNA in hepatic tissueM Buti, J C Lopez-Talavera, H Allende, et al.
Hepatology (Baltimore, Md.)|January 1, 1995
Determination of hepatitis delta virus RNA by polymerase chain reaction in acute and chronic delta infectionR Jardi, M Buti, M Cotrina, et al.
Journal of Virological Methods|December 1, 1994
Comparative analysis of serological markers of chronic delta infection: HDV-RNA, serum HDAg and anti-HD IgMR Jardi, M Buti, F Rodriguez, et al.
Alimentary Pharmacology & Therapeutics|June 4, 2005
Changes in different regions of hepatitis B virus gene in hepatitis B 'e' antigen-negative patients with chronic hepatitis B: the effect of long-term lamivudine therapyM Buti, R Jardi, F Rodriguez-Frias, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Medicina Clinica|May 11, 1985
[Infection by delta agent in drug addicts]M Buti, R Esteban, J M Rodrigo, et al.
Journal of Hepatology|February 1, 1987
Anti-HD IgM as a marker of chronic delta infectionM Buti, R Esteban, J I Esteban, et al.
Journal of Medical Virology|November 1, 1988
Epidemiology of delta infection in SpainM Buti, R Esteban, R Jardi, et al.
Journal of Hepatology|May 1, 1994
Etiology of acute sporadic hepatitis in Spain: the role of hepatitis C and E virusesM Buti, R Jardi, F Rodriguez-Frias, et al.
Journal of Hepatology|April 29, 1998
Transient emergence of hepatitis B variants in a patient with chronic hepatitis B resistant to lamivudineM Buti, R Jardi, M Cotrina, et al.
The Journal of Infectious Diseases|March 23, 2001
Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis BM Buti, F Sánchez, M Cotrina, et al.
Progress in Clinical and Biological Research|January 1, 1993
Serological diagnosis of chronic delta infection: correlation between serological markers and hepatitis delta virus RNA in hepatic tissueM Buti, J C Lopez-Talavera, H Allende, et al.
Hepatology (Baltimore, Md.)|January 1, 1995
Determination of hepatitis delta virus RNA by polymerase chain reaction in acute and chronic delta infectionR Jardi, M Buti, M Cotrina, et al.
Journal of Virological Methods|December 1, 1994
Comparative analysis of serological markers of chronic delta infection: HDV-RNA, serum HDAg and anti-HD IgMR Jardi, M Buti, F Rodriguez, et al.
Alimentary Pharmacology & Therapeutics|June 4, 2005
Changes in different regions of hepatitis B virus gene in hepatitis B 'e' antigen-negative patients with chronic hepatitis B: the effect of long-term lamivudine therapyM Buti, R Jardi, F Rodriguez-Frias, et al.
Pageof 6